| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 4e-06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 5e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.23 | 0.0003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |